Nippon Active Value Fund PLC/Fund
189.00
10-January-25 03:35:32
15 minutes delayed
Stocks
-0.75
-0.40%
Today's range
189.00 - 189.00
ISIN
N/A
Source
Cboe
-
Wallace Advisory Group LLC Invests $577,000 in EPAM Systems, Inc. (NYSE:EPAM)
14 Jan 2025 08:36:16 By Buzz FX
-
Barclays Forecasts Strong Price Appreciation for SolarEdge Technologies (NASDAQ:SEDG) Stock
14 Jan 2025 08:36:16 By Buzz FX
-
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Antero Resources (NYSE:AR) Stock
14 Jan 2025 08:36:16 By Buzz FX
-
Choice Hotels International (NYSE:CHH) Receives "Underweight" Rating from Morgan Stanley
14 Jan 2025 08:36:16 By Buzz FX
-
Element Solutions' (ESI) Neutral Rating Reaffirmed at Bank of America
14 Jan 2025 08:36:16 By Buzz FX
-
Deutsche Bank Aktiengesellschaft Initiates Coverage on EastGroup Properties (NYSE:EGP)
14 Jan 2025 08:36:16 By Buzz FX
-
Traders Target Rare Gap in Fed-ECB Paths to Juice Credit Returns
14 Jan 2025 08:30:16 By Buzz FX
-
Robust US Economy May Not Need Trump's Big Reforms | Newsmax.com
14 Jan 2025 08:25:28 By Buzz FX
-
14 Jan 2025 08:21:27 By Buzz FX
-
Quantum-Si (NASDAQ:QSI) Given Buy Rating at HC Wainwright
14 Jan 2025 08:16:16 By Buzz FX
-
Truist Financial Has Lowered Expectations for Caesars Entertainment (NASDAQ:CZR) Stock Price
14 Jan 2025 08:16:16 By Buzz FX
-
Barclays Increases Netflix (NASDAQ:NFLX) Price Target to $715.00
14 Jan 2025 08:16:16 By Buzz FX
-
Merit Medical Systems (NASDAQ:MMSI) Earns "Buy" Rating from Needham & Company LLC
14 Jan 2025 08:16:16 By Buzz FX
-
Fortinet (NASDAQ:FTNT) Earns "Market Perform" Rating from Raymond James
14 Jan 2025 08:16:16 By Buzz FX
-
14 Jan 2025 08:16:16 By Buzz FX
-
HC Wainwright Reiterates "Buy" Rating for Rigel Pharmaceuticals (NASDAQ:RIGL)
14 Jan 2025 08:16:16 By Buzz FX
-
NovoCure (NASDAQ:NVCR) Earns "Buy" Rating from HC Wainwright
14 Jan 2025 08:16:16 By Buzz FX
-
HC Wainwright Reaffirms Buy Rating for Biomea Fusion (NASDAQ:BMEA)
14 Jan 2025 08:16:16 By Buzz FX
-
PACCAR (NASDAQ:PCAR) Upgraded by Bank of America to "Buy" Rating
14 Jan 2025 08:16:16 By Buzz FX
-
Corvus Pharmaceuticals (NASDAQ:CRVS) Receives "Buy" Rating from HC Wainwright
14 Jan 2025 08:16:16 By Buzz FX